US-based Amneal Pharmaceuticals Inc on Tuesday said it has acquired Ahmedabad-based drug firm Puniska Healthcare Pvt Ltd for a total value of around Rs 700 crore. The acquisition significantly enhances Amneal's injectables manufacturing infrastructure, capabilities, and capacity to support the US market and serve as a foundation for international markets, the company said in a statement. Puniska includes a 293,000 square foot, manufacturing facility in Ahmedabad, with a number of sterile injectable production lines. Production capabilities include robotic, aseptic and lyophilize vial lines, emulsion line, and large-volume parenteral bag line, it added. The acquisition also brings to the company approximately 550 Puniska employees with key capabilities in injectables manufacturing, R&D and commercialisation, Amneal said. "This acquisition is a pivotal step that meaningfully enhances our injectables capabilities for the US market and enables international expansion, including in ...
from Companies https://ift.tt/3klj4ZM
via IFTTT
Subscribe to:
Post Comments (Atom)
Omicron has cast a shadow of uncertainty on growth outlook: IndiGo CEO
However, the airline is stronger now when compared to situation in 2020 during the first wave of the pandemic, says Ronojoy Dutta from Com...
-
New research links walnut consumption as a contributing factor that could suppress growth and survival of breast cancers. from Top Health ...
-
Researchers report on chimpanzees in Guinea fishing and consuming freshwater crabs, something previously undiscovered. The article describes...
-
Russian President Vladimir Putin and Indian Prime Minister Narendra Modi held summit talks on Friday in New Delhi from Economy & Polic...
No comments:
Post a Comment